Counsel patients that their Mirena IUD retains contraceptive effectiveness for extended use up to 8 years. The cumulative failure rate for years 6 through 8 was 0.68%, similar to reported rates for the first 5 years of use.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3122/jabfm.2024.240037R0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Keep on Keeping on - Mirena IUD for 8 Years.
J Am Board Fam Med
January 2025
From the University of Missouri, Columbia, MO (SHM, CT, LM).
Counsel patients that their Mirena IUD retains contraceptive effectiveness for extended use up to 8 years. The cumulative failure rate for years 6 through 8 was 0.68%, similar to reported rates for the first 5 years of use.
View Article and Find Full Text PDFLong-term effects of endometrial resection or ablation in combination with levonorgestrel intrauterine device on bleeding patterns.
Arch Gynecol Obstet
December 2024
Department of Obstetrics and Gynecology, Odense University Hospital, Kløvervænget 23, 5000, Odense, Denmark.
Objective: Endometrial resection and ablation are minimal invasive surgeries used to treat women with abnormal uterine bleeding (AUB). Both may be followed by a high reoperation rate up to 24%. However, some studies suggest that this may be improved by adding a levonorgestrel intrauterine device (LNG-IUD) immediately following surgery.
View Article and Find Full Text PDFLEVONORGESTREL INTRAUTERINE DEVICE PLACEMENT IN UTERINE ANOMALIES: A CASE SERIES.
J Pediatr Adolesc Gynecol
December 2024
Children's Minnesota Department of Pediatric and Adolescent Gynecology.
Background: Levonorgestrel intrauterine devices (IUDs) provide effective contraception and medical benefits. They are safe for even severely medically complex patients. The CDC Medical Eligibility Criteria (MEC) states IUDs are category 4 for people with uterine cavity distortions, however there are previous case reports of their successful use in this population.
View Article and Find Full Text PDFComparison of levonorgestrel in different forms and copper intrauterine devices for emergency contraception: A systematic review and meta-analysis.
Eur J Obstet Gynecol Reprod Biol
December 2024
Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Brazil.
Objective: Emergency contraception serves as the only dependable method for women to prevent pregnancy following unprotected sex. Among emergency contraception methods, the copper intrauterine device provides continuous, highly effective contraception for over a decade. This study aimed to evaluate the effectiveness, safety, and side effects of the copper intrauterine device over methods containing levonorgestrel for emergency contraception.
View Article and Find Full Text PDFContraception with levonorgestrel-releasing intrauterine system versus copper intrauterine device: a meta-analysis of randomized controlled trials.
EClinicalMedicine
December 2024
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Background: Globally, approximately 19.4% of women of reproductive age use intrauterine contraception, encompassing both copper intrauterine devices (Cu-IUDs) and levonorgestrel intrauterine devices (LNG-IUDs). Despite current guidelines endorsing intrauterine contraception as a primary method, there remains debate regarding device selection.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!